Abner Herrman & Brock’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26M Sell
202,424
-45
-0% -$5.27K 2.47% 13
2026
Q1
$24.4M Buy
202,469
+4,155
+2% +$480K 2.69% 14
2025
Q4
$20.9M Buy
198,314
+187,919
+1,808% +$17.6M 2.13% 20
2025
Q3
$872K Buy
+10,395
New +$856K 0.09% 60
2025
Q1
Sell
-36,461
Closed -$3.63M 55
2024
Q4
$3.63M Sell
36,461
-98,749
-73% -$10.2M 0.45% 42
2024
Q3
$15.4M Buy
135,210
+492
+0.4% +$58.5K 1.85% 26
2024
Q2
$16.7M Sell
134,718
-3,831
-3% -$493K 2.11% 22
2024
Q1
$18.3M Sell
138,549
-2,988
-2% -$368K 2.28% 21
2023
Q4
$15.4M Sell
141,537
-2,521
-2% -$262K 2.17% 24
2023
Q3
$14.8M Sell
144,058
-53,107
-27% -$5.72M 2.27% 23
2023
Q2
$22.8M Buy
197,165
+47
+0% +$5.34K 3.34% 8
2023
Q1
$21M Sell
197,118
-82
-0% -$8.85K 3.17% 8
2022
Q4
$21.9M Sell
197,200
-887
-0.4% -$90.7K 3.36% 5
2022
Q3
$17.1M Buy
198,087
+6,445
+3% +$575K 3.13% 10
2022
Q2
$17.5M Buy
191,642
+1,808
+1% +$160K 3.02% 12
2022
Q1
$15.6M Buy
+189,834
New +$15M 2.19% 23
2021
Q2
Sell
-201,273
Closed -$14.8M 97
2021
Q1
$14.8M Sell
201,273
-26,886
-12% -$1.98M 2.24% 19
2020
Q4
$17.8M Sell
228,159
-17,589
-7% -$1.35M 2.77% 11
2020
Q3
$19.5M Sell
245,748
-9,024
-4% -$707K 3.28% 8
2020
Q2
$18.8M Sell
254,772
-16,943
-6% -$1.28M 3.38% 7
2020
Q1
$19.9M Sell
271,715
-14,602
-5% -$1.15M 4.52% 3
2019
Q4
$24.8M Sell
286,317
-24,942
-8% -$2.05M 3.7% 5
2019
Q3
$25M Sell
311,259
-14,867
-5% -$1.19M 3.69% 5
2019
Q2
$26.1M Sell
326,126
-3,468
-1% -$266K 3.74% 6
2019
Q1
$26.2M Buy
329,594
+3,263
+1% +$244K 4.03% 4
2018
Q4
$23.8M Buy
326,331
+45,066
+16% +$3.18M 4.34% 4
2018
Q3
$19M Buy
281,265
+14,930
+6% +$951K 2.72% 9
2018
Q2
$15.4M Buy
266,335
+10,386
+4% +$586K 2.4% 11
2018
Q1
$13.3M Buy
255,949
+13,611
+6% +$735K 2.11% 14
2017
Q4
$13M Sell
242,338
-26,785
-10% -$1.48M 2.19% 14
2017
Q3
$16.4M Buy
269,123
+12,578
+5% +$763K 2.91% 7
2017
Q2
$15.7M Buy
256,545
+2,593
+1% +$158K 2.97% 7
2017
Q1
$15.4M Sell
253,952
-842
-0.3% -$51.1K 3.06% 4
2016
Q4
$14.6M Sell
254,794
-32,150
-11% -$1.88M 3.07% 3
2016
Q3
$17.1M Buy
286,944
+2,462
+0.9% +$144K 3.88% 1
2016
Q2
$16.1M Buy
284,482
+6,065
+2% +$323K 3.75% 1
2016
Q1
$14.1M Buy
278,417
+85,649
+44% +$4.19M 3.53% 1
2015
Q4
$9.72M Sell
192,768
-4,873
-2% -$246K 5.01% 2
2015
Q3
$9.61M Buy
197,641
+1,341
+0.7% +$71.2K 5.13% 1
2015
Q2
$10.7M Buy
196,300
+4,223
+2% +$237K 5.39% 1
2015
Q1
$10.5M Buy
192,077
+62
+0% +$3.51K 5.36% 1
2014
Q4
$10.4M Sell
192,015
-86,379
-31% -$4.81M 5.28% 1
2014
Q3
$15.7M Buy
278,394
+2,175
+0.8% +$122K 4.63% 1
2014
Q2
$15.2M Buy
276,219
+10,674
+4% +$582K 4.6% 1
2014
Q1
$14.4M Buy
265,545
+37,003
+16% +$1.92M 4.61% 1
2013
Q4
$10.8M Buy
228,542
+153,060
+203% +$7M 3.84% 2
2013
Q3
$3.43M Sell
75,482
-23,104
-23% -$1.05M 2.28% 14
2013
Q2
$4.37M Buy
+98,586
New +$4.4M 1.85% 21

Other funds holding MRK

Abner Herrman & Brock's MRK Position: Q2 2026 in Review

Abner Herrman & Brock reduced its Merck (MRK) stake by 0.02% in Q2 2026, selling an estimated $5.27K and leaving 202,424 shares worth $26M. The position accounts for 2.47% of the portfolio, ranked #13.

Abner Herrman & Brock first reported a position in MRK in Q2 2013 and has held it in 48 quarters since. The position peaked at $26.2M in Q1 2019. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Abner Herrman & Brock held 202,424 shares of Merck worth $26M as of Q2 2026.
  • Abner Herrman & Brock sold 45 Merck shares in Q2 2026, an estimated $5.27K.
  • Merck made up 2.47% of Abner Herrman & Brock's portfolio in Q2 2026, its #13 holding.
  • Abner Herrman & Brock first reported a position in Merck in Q2 2013 and has held it in 48 quarters since.
  • Abner Herrman & Brock's Merck position peaked at $26.2M in Q1 2019.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Abner Herrman & Brock's 13F filing for Q2 2026, filed 8 Jul 2026.